TWINNING ON DNA-BASED CANCER VACCINES
(VACTRAIN)
Start date: Jan 1, 2016,
End date: Dec 31, 2018
PROJECT
FINISHED
The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Coordinator
RIGAS STRADINA UNIVERSITATE
€ 357 575,00- Dzirciema street 16 1007 RIGA (Latvia)
Details
- 100% € 999 475,00
-
H2020-EU.4.b.
- Project on CORDIS Platform
3 Partners Participants
KAROLINSKA INSTITUTET
€ 327 295,00- Nobels Vag 5 17177 STOCKHOLM (Sweden)
UNIWERSYTET LODZKI
€ 165 855,00- UL PREZYDENTA GABRIELA NARUTOWICZA 68 90 136 LODZ (Poland)
R.E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY ONCOLOGY AND RADIOBIOLOGY OF NATIONAL ACADEMY OF SCIENCES OF UKRAINE
€ 148 750,00- VASYLKIVSKA STR 45 03022 KYIV (Ukraine)